Zevra Therapeutics, Inc. ZVRA 深 滬
已收盤 05-08 16:00:00 美东时间
11.13
+0.130
+1.18%
華盛通- 最 高11.595
- 今 開11.14
- 成交量 265.02万股
- 最 低 10.78
- 昨 收 11.00
- 總市值 65.79万
- 52周最高 13.16
- 市盈率 靜 8.21
- 換手率 4483.18%
- 52周最低 7.16
- 委 比 97.43%
- 總股本 5.91万
- 歷史最高 418.40
- 量 比 1.71
- 振 幅 7.41%
- 歷史最低 0.206
- 每 手 1
- 風險率 1.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Guggenheim Maintains Buy on Zevra Therapeutics, Raises Price Target to $25
Guggenheim analyst Eddie Hickman maintains Zevra Therapeutics (NASDAQ:ZVRA) with a Buy and raises the price target from $23 to $25.
05-08 21:29
Zevra Therapeutics shares are trading lower. The company reported its Q1 financial results.
Zevra Therapeutics shares are trading lower. The company reported its Q1 financ...
05-08 00:50
CORRECTION: Zevra Therapeutics Q1 Adj. EPS $0.18 Beats $0.08 Estimate, Sales $36.220M Beat $31.960M Estimate
Zevra Therapeutics (NASDAQ:ZVRA) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.08 by 125 percent. This is a 400 percent increase over losses of $(0.06) per share from the
05-07 05:23
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
Zevra Shares Jump After Selling SDX Portfolio For $50M
Zevra Therapeutics Inc. shares are trading higher on Monday after it agreed to sell its SDX Portfolio to Commave for $50 million.
03-16 21:26
美股牛股 | VYGR飙升21%，Q4亏损收窄及销售额超预期；Figure大涨超20%
VYGR飙升21%，Q4亏损收窄及销售额超预期；Figure大涨超20%，进军汽车贷款市场获华尔街唱多；Stagwell涨逾17%，引入AppLovin先进的移动广告平台>>
03-11 16:04
Why Is Zevra Therapeutics Stock Trading Higher Today?
Zevra Therapeutics jumped in Tuesday premarket trading after partnering with GeneDx to expand NPC genetic testing and reporting fourth-quarter earnings and revenue that beat estimates.
03-11 02:45
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Zevra Therapeutics (NASDAQ:ZVRA) stock moved upwards by 20.6% to $11.0...
03-10 05:05
Zevra Therapeutics shares are trading higher after the company reported better-than-expected Q4 financial results.
Zevra Therapeutics shares are trading higher after the company reported better-...
03-10 04:14
